stoxline Quote Chart Rank Option Currency Glossary
  
The Oncology Institute, Inc. (TOI)
3.23  0.26 (8.75%)    07-16 16:00
Open: 3.24
High: 3.39
Volume: 2,612,603
  
Pre. Close: 2.97
Low: 3.1201
Market Cap: 297(M)
Technical analysis
2025-07-17 8:50:13 AM
Short term     
Mid term     
Targets 6-month :  3.95 1-year :  4.62
Resists First :  3.39 Second :  3.95
Pivot price 2.57
Supports First :  2.54 Second :  2.01
MAs MA(5) :  3.08 MA(20) :  2.52
MA(100) :  2.08 MA(250) :  1.07
MACD MACD :  0.1 Signal :  0
%K %D K(14,3) :  83.5 D(3) :  87.7
RSI RSI(14): 63.9
52-week High :  3.5 Low :  0.12
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ TOI ] has closed below upper band by 8.3%. Bollinger Bands are 66.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 3.39 - 3.41 3.41 - 3.42
Low: 3.09 - 3.1 3.1 - 3.11
Close: 3.2 - 3.23 3.23 - 3.25
Company Description

The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.

Headline News

Wed, 16 Jul 2025
The Oncology Institute stock initiated with Buy rating at B.Riley By Investing.com - Investing.com South Africa

Tue, 15 Jul 2025
The Oncology Institute, Inc. (NASDAQ:TOI) Stock Rockets 30% But Many Are Still Ignoring The Company - simplywall.st

Mon, 14 Jul 2025
Oncology Institute Names new Chief Administrative Officer - MarketScreener

Mon, 14 Jul 2025
The Oncology Institute Names Kristin England as Chief Administrative Officer - GlobeNewswire

Mon, 14 Jul 2025
Former McKesson US Oncology Leader Joins Oncology Institute to Drive National Growth Strategy - Stock Titan

Sat, 12 Jul 2025
Oncology Institute (NASDAQ:TOI) pops 24% this week, taking one-year gains to 566% - simplywall.st

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Care Facilities
Shares Out 92 (M)
Shares Float 67 (M)
Held by Insiders 9.2 (%)
Held by Institutions 34.6 (%)
Shares Short 2,410 (K)
Shares Short P.Month 1,870 (K)
Stock Financials
EPS -0.7
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.05
Profit Margin -16 %
Operating Margin -9.5 %
Return on Assets (ttm) -17.7 %
Return on Equity (ttm) -277.7 %
Qtrly Rev. Growth 10.3 %
Gross Profit (p.s.) 0.64
Sales Per Share 4.38
EBITDA (p.s.) -0.5
Qtrly Earnings Growth 0 %
Operating Cash Flow -16 (M)
Levered Free Cash Flow 6 (M)
Stock Valuations
PE Ratio -4.62
PEG Ratio 0
Price to Book value 53.83
Price to Sales 0.73
Price to Cash Flow -18.99
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android